Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution - A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial (Whistler)

NCT05938699 is registered in ClinicalTrials.gov with Nicox Ophthalmics, Inc. as lead sponsor.

NCT NCT05938699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution - A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial (Whistler)
Lead sponsor
Nicox Ophthalmics, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
December 12, 2023
Completion date
March 17, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma